Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era

Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on ...
AOL

Pfizer's mRNA flu shot outperforms standard flu vaccine in late-stage trial

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...
WFMZ-TV

New Trial Shows Pfizer’s mRNA Flu Shot Beats Traditional Flu Vaccine

Pfizer’s mRNA flu shot prevented more flu-like illness than a standard vaccine More than 18,000 adults took part in the study Side effects were mild and went away quickly FRIDAY, Nov. 21, 2025 ...
Drexel University

Revolutionary Biochemist and Nobel Laureate Katalin Karikó to Address Drexel College of Medicine Class of 2026 During Commencement

Katalin Karikó, PhD, co-inventor on mRNA-related applications of non-immunogenic, nucleoside-modified RNA for vaccines and ...
Reuters

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

LONDON, April 1 (Reuters) - Vaccine makers Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to ...
Medical Xpress

New trial shows Pfizer's mRNA flu shot beats traditional flu vaccine

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported. The Pfizer flu vaccine uses the same type of messenger RNA science that was used in the ...